Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Complete remissions in non small cell lung cancerJ Klastersky, J P Sculier, P Mommen
European Journal of Cancer & Clinical Oncology|July 1, 1986
Placebo controlled pneumococcal immunization in patients with bronchogenic carcinomaJ Klastersky, P Mommen, F Cantraine, et al.
Anticancer Research|March 4, 2000
Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studiesT Berghmans, J Klastersky, E Markiewicz, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Subrenal capsule assay of fresh human tumors: problems and pitfallsJ Abrams, D Jacobovitz, P Dumont, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.comJ P Sculier, J J Lafitte, T Berghmans, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working PartyJ J Body, J C Dumon, J P Sculier, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2002
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapyJ P Sculier, T Berghmans, J J Lafitte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.
Lung Cancer (Amsterdam, Netherlands)|July 12, 2005
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesotheliomaT Berghmans, J J Lafitte, M Paesmans, et al.
Pageof 3